Jeff Walenta

Regulatory Affairs Branch, Cancer Therapy Evaluation Program @National Cancer Institute (NCI)

Rockville, MD, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2023 — Present

Regulatory Affairs Branch, Cancer Therapy Evaluation Program @National Cancer Institute (NCI)

View department →

Rockville, MD, US

The mission of the Cancer Therapy Evaluation Program (CTEP) is to improve the lives of cancer patients by finding better ways to treat, control and cure cancer. CTEP accomplishes this mission by funding an extensive national program of cancer research and by sponsoring clinical trials to evaluate new anti-cancer agents, with a particular emphasis on translational research to elucidate molecular targets and mechanisms of drug effects.

EDUCATION

2000 — 2002

Washington University in St. Louis - Olin Business School

MBA

1986 — 1990

University of Maryland

BS Biological Sciences

SKILLS

Cell BiologyBiotechnologyChemistryScienceBiochemistryMicrobiologyMedical DevicesRegulatory AffairsLifesciencesVaccinesLicensingCommercializationGenomicsPharmaceutical IndustryFdaTechnology TransferCancerBiopharmaceuticalsClinical TrialsDrug DiscoveryPatentsIntellectual PropertyBioinformaticsInfectious DiseasesHplcImmunologyProtein ChemistryCellLife SciencesGenetics

ABOUT JEFF WALENTA

Technology Transfer

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jeff Walenta — Regulatory Affairs Branch, Cancer Therapy Evaluation Program at National Cancer Institute (NCI) in Rockville, MD, US | Unifers